BioCryst Pharmaceuticals | 매출원가

Cost Of Sales 변화 날짜
Alnylam Pharmaceuticals USD 85.86M 1.55M 2023-12
Chugai Pharma JPY 78.26B 13.41B 2023-09
Daiichi Sankyo JPY 94.74B 1.06B 2023-09
Gilead Sciences USD 1.61B 46M 2023-12
GlaxoSmithKline GBP 2.24B 343M 2023-09
Incyte USD 64.05M 9.66M 2023-12
Intra Cellular Therapies USD 10.7M 1.57M 2023-12
Ionis Pharmaceuticals USD 3.06M 871K 2023-12
Neurocrine Biosciences USD 11.2M 300K 2023-09
PTC Therapeutics USD 29.12M 19.62M 2023-12
Regeneron Pharmaceuticals USD 517M 80.6M 2023-12
Roche Holding CHF 7.62B 1.33B 2023-06
Sarepta Therapeutics USD 37.03M 2.9M 2023-09
Ultragenyx Pharmaceutical USD 12.05M 1.06M 2023-12
Vertex Pharmaceuticals USD 318.7M 10.1M 2023-09



BioCryst Pharmaceuticals 매출원가 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.